The Shotlee Journal
Browse Shotlee articles about Ozempic.
Showing 9 / 1090 Ozempic articles
New research presented at Digestive Disease Week 2026 suggests a minimally invasive 'gut reset' procedure could help patients maintain weight loss after discontinuing GLP-1 medications like Ozempic and Wegovy. The findings address a major challenge in obesity treatment: weight regain after stopping therapy.
In a candid interview, acclaimed author Emma Copley Eisenberg shares insights into her newest book Fat Swim, a collection of Philly-set stories exploring body image and identity. A self-identified fat liberationist, she critiques the rise of Ozempic ads and champions body autonomy amid shifting cultural attitudes toward fatness.
Ozempic and other GLP-1 medications are transforming figures in Hollywood and newsrooms alike, with before and after pics of personalities like Oprah Winfrey and Joy Behar showcasing undeniable weight loss. A 2024 study highlights their history since 1986, exploding in popularity post-Wegovy's 2021 FDA approval for weight loss. Spot the telltale Ozempic neck and hands that give away users.
Pfizer's GLP-1 weight management drug Xianweiying is available for pre-order on JD.com in China, intensifying rivalry in a market projected to reach billions. Priced at 489 yuan ($72) for a 1.2 ml injector pen with shipping from April 27, it challenges leaders like Novo Nordisk's Wegovy and Innovent's Xinermei. This move bolsters Pfizer's position via licensing from Sciwind.
The mantra 'once an accident, twice a coincidence, three times a trend' fuels bad journalism—and worse, risky medicine. A New Yorker investigation exposes clinics pushing unproven peptides for healing and longevity, backed by RFK Jr. While semaglutide proves the exception, most lack evidence and pose real harms.
Started GLP-1s for weight loss or blood sugar control but seeing no results? New research in Genome Medicine reveals that 10% of people carry PAM gene variants linked to weaker responses. Experts explain genetics, common pitfalls, testing, and effective alternatives to help you succeed.
Christina Aguilera turned heads at the Breakthrough Prize Ceremony, appearing 'thinner than ever' in a plunging black leather dress that highlighted her minuscule waist. Amid ongoing Ozempic rumors, fans commented 'Ozempic strikes again' on her super-slim frame. This sighting reignites discussions on celebrity weight loss and GLP-1 medications.
Country music sensation Luke Combs is turning down GLP-1 medications for weight loss, opting for the hard road instead. In a candid New York Times interview, he shares fears about his appearance affecting his career and why 'that stuff scares me more than the benefits.' This stance highlights debates around quick fixes versus lifelong habits in weight management.
A groundbreaking study in Nature Health sifted through 410,198 Reddit posts mentioning semaglutide or tirzepatide, revealing hidden side effects like reproductive issues and temperature fluctuations that go beyond typical nausea. While 43.5% of users reported symptoms, experts like Dr. Jeffrey Lee stress the need for clinical confirmation. This guide explores these findings and what they mean for patients.
